STK-001-DS-501 SWALLOWTAIL Study – An Open-Label Extension Study for Patients with Dravet Syndrome who Previously Participated in Studies of STK-001

NCT04740476

SWALLOWTAIL Study – An Open-Label Extension Study for Patients with Dravet Syndrome who Previously Participated in Studies of STK-001

Associated Conditions

Dravet Syndrome

Principal Investigator

Sponsor

Stokes Therapeutics

The main purpose of this extension study is to look at how safe STK-001 is when given every 4 months over a year. The study will also look at how well a person can tolerate receiving multiple doses of the study drug.

This study is currently enrolling.